Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
Descripción del Articulo
DESIGN: This multicentric prospective, double-blind study compared the safety and efficacy of clindamvcin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients wild mild to moderate pelvic inflammatory disease, diagnosed through laparoscopy. MATERIAL AND METHODS: Prior...
Autores: | , , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2015 |
Institución: | Sociedad Peruana de Obstetricia y Ginecología |
Repositorio: | Revista SPOG - Revista Peruana de Ginecología y Obstetricia |
Lenguaje: | español |
OAI Identifier: | oai:ojs.spog:article/982 |
Enlace del recurso: | http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982 |
Nivel de acceso: | acceso abierto |
id |
2304-5132_f257d7b0697ff13980ec6aa3018c4477 |
---|---|
oai_identifier_str |
oai:ojs.spog:article/982 |
network_acronym_str |
2304-5132 |
repository_id_str |
. |
network_name_str |
Revista SPOG - Revista Peruana de Ginecología y Obstetricia |
spelling |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in LimaTratamiento oral de clindamicina y ciprofloxacina versus ceftriaxona intramuscular y doxiciclina oral t el tratamiento ambulatorio de la enfermedad pélvica inflamatoria leve a moderada en dos Hospitales de LimaDíaz, VíctorMaradiegue, EduardoEscudero, FranciscoSa, PedroDESIGN: This multicentric prospective, double-blind study compared the safety and efficacy of clindamvcin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients wild mild to moderate pelvic inflammatory disease, diagnosed through laparoscopy. MATERIAL AND METHODS: Prior to the treatment, samples were taken from endocervix, endometrium, abdominal cavity, and in cases with positive cultures to aerobes and anaerohes, Neisseria gonorrhoeae and Chlamydia trachomatis. From the total of 65 patients enrolled, 63 were evaluated for efficacy. RESULTS: The prevalent bacteriae were staphylococcus and streptococcus (among aerobes) and peptostreptococcus and bacteroids (among anaerobes). N. gonorrhoeae was present in 1, 8% (1) of the 53 evaluable patients and c. trachomatis in 9,4% (5). Clinical cure was 85,7% (24 from 28) in the clindamycin plus ciprofloxacin group and 68% (17 from 25) in the ceftriaxone plus doxycycline group. CONCLUSIONS: Both treatment regimens for outpatients with, mild to moderate PID were similar in effectivity and safety.DISEÑO: Este estudio multicéntrico, prospectivo, doble ciego, comparó la seguridad y eficacia de clindamicina y ciprofloxacina versus ceftriaxona y doxiciclina en el tratamiento de pacientes ambulatorios con enfermedad inflamatoria pélvica (EIP) leve a moderada diagnosticada laparoscópicamente. MATERIAL Y METODOS: Se tomó muestras del endocérvix, endometrio y cavidad abdominal antes del tratamiento y en los casos con cultivos positivos a aerobios, anaerobios, Neisseria gonorrhoeae y Chlamydia trachomatis. De las 65pacientes enroladas, 63 fueron evaluables para eficacia. RESULTADOS: Las bacterias más prevalentes fueron esta filocos y estreptococos (entre aerobios) y peptoestreptococos y bacteroides (entre N. gonorrhoeae estuvo presente en 1, 8% (1) las 53pacientes evaluables y C. trachomatis en el 9,4% (5). La cura clínica fue de 85,7% (24 de 28) en el grupo de clindamicina y ciprofloxacina y 68% (17 de 25) en el grupo de ceftriaxona doxiciclina. CONCLUSION.- Los dos regímenes de tratamiento para pacientes ambulatorias con EIP leve a moderada fueron similarmente efectivos y seguros.Sociedad Peruana de Obstetricia y Ginecología2015-06-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://www.spog.org.pe/web/revista/index.php/RPGO/article/view/98210.31403/rpgo.v44i982Revista Peruana de Ginecología y Obstetricia; Vol. 44, Núm. 1 (1998); 21-272304-51322304-5124reponame:Revista SPOG - Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspahttp://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982/944info:eu-repo/semantics/openAccess2021-05-31T15:51:49Zmail@mail.com - |
dc.title.none.fl_str_mv |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima Tratamiento oral de clindamicina y ciprofloxacina versus ceftriaxona intramuscular y doxiciclina oral t el tratamiento ambulatorio de la enfermedad pélvica inflamatoria leve a moderada en dos Hospitales de Lima |
title |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima |
spellingShingle |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima Díaz, Víctor |
title_short |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima |
title_full |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima |
title_fullStr |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima |
title_full_unstemmed |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima |
title_sort |
Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima |
dc.creator.none.fl_str_mv |
Díaz, Víctor Maradiegue, Eduardo Escudero, Francisco Sa, Pedro |
author |
Díaz, Víctor |
author_facet |
Díaz, Víctor Maradiegue, Eduardo Escudero, Francisco Sa, Pedro |
author_role |
author |
author2 |
Maradiegue, Eduardo Escudero, Francisco Sa, Pedro |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
|
dc.description.none.fl_txt_mv |
DESIGN: This multicentric prospective, double-blind study compared the safety and efficacy of clindamvcin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients wild mild to moderate pelvic inflammatory disease, diagnosed through laparoscopy. MATERIAL AND METHODS: Prior to the treatment, samples were taken from endocervix, endometrium, abdominal cavity, and in cases with positive cultures to aerobes and anaerohes, Neisseria gonorrhoeae and Chlamydia trachomatis. From the total of 65 patients enrolled, 63 were evaluated for efficacy. RESULTS: The prevalent bacteriae were staphylococcus and streptococcus (among aerobes) and peptostreptococcus and bacteroids (among anaerobes). N. gonorrhoeae was present in 1, 8% (1) of the 53 evaluable patients and c. trachomatis in 9,4% (5). Clinical cure was 85,7% (24 from 28) in the clindamycin plus ciprofloxacin group and 68% (17 from 25) in the ceftriaxone plus doxycycline group. CONCLUSIONS: Both treatment regimens for outpatients with, mild to moderate PID were similar in effectivity and safety. DISEÑO: Este estudio multicéntrico, prospectivo, doble ciego, comparó la seguridad y eficacia de clindamicina y ciprofloxacina versus ceftriaxona y doxiciclina en el tratamiento de pacientes ambulatorios con enfermedad inflamatoria pélvica (EIP) leve a moderada diagnosticada laparoscópicamente. MATERIAL Y METODOS: Se tomó muestras del endocérvix, endometrio y cavidad abdominal antes del tratamiento y en los casos con cultivos positivos a aerobios, anaerobios, Neisseria gonorrhoeae y Chlamydia trachomatis. De las 65pacientes enroladas, 63 fueron evaluables para eficacia. RESULTADOS: Las bacterias más prevalentes fueron esta filocos y estreptococos (entre aerobios) y peptoestreptococos y bacteroides (entre N. gonorrhoeae estuvo presente en 1, 8% (1) las 53pacientes evaluables y C. trachomatis en el 9,4% (5). La cura clínica fue de 85,7% (24 de 28) en el grupo de clindamicina y ciprofloxacina y 68% (17 de 25) en el grupo de ceftriaxona doxiciclina. CONCLUSION.- Los dos regímenes de tratamiento para pacientes ambulatorias con EIP leve a moderada fueron similarmente efectivos y seguros. |
description |
DESIGN: This multicentric prospective, double-blind study compared the safety and efficacy of clindamvcin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients wild mild to moderate pelvic inflammatory disease, diagnosed through laparoscopy. MATERIAL AND METHODS: Prior to the treatment, samples were taken from endocervix, endometrium, abdominal cavity, and in cases with positive cultures to aerobes and anaerohes, Neisseria gonorrhoeae and Chlamydia trachomatis. From the total of 65 patients enrolled, 63 were evaluated for efficacy. RESULTS: The prevalent bacteriae were staphylococcus and streptococcus (among aerobes) and peptostreptococcus and bacteroids (among anaerobes). N. gonorrhoeae was present in 1, 8% (1) of the 53 evaluable patients and c. trachomatis in 9,4% (5). Clinical cure was 85,7% (24 from 28) in the clindamycin plus ciprofloxacin group and 68% (17 from 25) in the ceftriaxone plus doxycycline group. CONCLUSIONS: Both treatment regimens for outpatients with, mild to moderate PID were similar in effectivity and safety. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-06-19 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982 10.31403/rpgo.v44i982 |
url |
http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982 |
identifier_str_mv |
10.31403/rpgo.v44i982 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982/944 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedad Peruana de Obstetricia y Ginecología |
publisher.none.fl_str_mv |
Sociedad Peruana de Obstetricia y Ginecología |
dc.source.none.fl_str_mv |
Revista Peruana de Ginecología y Obstetricia; Vol. 44, Núm. 1 (1998); 21-27 2304-5132 2304-5124 reponame:Revista SPOG - Revista Peruana de Ginecología y Obstetricia instname:Sociedad Peruana de Obstetricia y Ginecología instacron:SPOG |
reponame_str |
Revista SPOG - Revista Peruana de Ginecología y Obstetricia |
collection |
Revista SPOG - Revista Peruana de Ginecología y Obstetricia |
instname_str |
Sociedad Peruana de Obstetricia y Ginecología |
instacron_str |
SPOG |
institution |
SPOG |
repository.name.fl_str_mv |
-
|
repository.mail.fl_str_mv |
mail@mail.com |
_version_ |
1701289838719795200 |
score |
13.982926 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).